LSA Global
DECEMBER 18, 2023
Net Promoter Score The Executive Team wanted the Manager Excellence Training For Biotech Managers to increase individual and team productivity while simultaneously raising employee engagement ratings and improving employee retention. The post LSA Global Delivers Manager Excellence Training For Biotech Managers appeared first on LSA Global.
LSA Global
DECEMBER 4, 2023
Satisfaction 131% Knowledge Gain 88% Net Promoter Score This global biotech leader knew that transforming from a successful individual contributor to effectively leading people doesn’t happen by accident — especially with scientists and highly technical employees. The new manager training results were: 93.5% Job Relevance 97.6%
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
LSA Global
JUNE 6, 2023
Redwood Shores, CA – LSA Global, the leading business consulting, coaching, and training firm that helps fast growth life science, technology, and service companies by powerfully aligning their culture and talent with strategy, today announced results for a Leading Teams Workshop at a leading Biotech company. Learn more about getting aligned.
LSA Global
NOVEMBER 27, 2023
Redwood Shores, CA – LSA Global, the leading business consulting, coaching, and training firm that helps fast growth life science, technology, and service companies by powerfully aligning their culture and talent with strategy, today announced results for a customized Leading Enterprise Training Program for Leaders of a fast growing Biotech Company.
LSA Global
JULY 25, 2023
96% Job Relevance 100% Satisfaction This fast growing Biotech client needed employees to understand that not all work is equally important and to prioritize and make decisions accordingly. The Prioritization Workshop for Biotech employees helped individual contributors to better manage their workload when everything feels like a top priority.
LSA Global
FEBRUARY 6, 2023
There is a lack of consistency in team members’ experience in product development and a lack of clarity and alignment around scope, accountability , roles, team norms , responsibilities, decision-making rights, and communication channels, resulting in misalignments , delays, and rework. Learn more about getting aligned.
Michael McKinney
MARCH 12, 2024
If sophisticated investors are involved — as often happens in biotech — the plan is undoubtedly subjected to intensive due diligence. The number of factors one would need to have considered, accounted for, and correctly predicted to have a “perfect plan” is comparable to the number of stars in the sky.
Expert insights. Personalized for you.
36 
Let's personalize your content